Explain this page
Arphra AIPlain-English read on Moderna, Inc.’s valuationInsider signal · 90d
Net sellers
Bought
$0
Sold
$265.0K
Txns
1
Over the trailing 90 days insiders are net sellers — $0 bought against $265.0K sold across 1 open-market Form-4 transactions. Much insider selling is scheduled (10b5-1); read the asymmetry, not any single print.
Open-market Form 4
· insider_tradesInsider transactions · last 730d
Net −$3.9M3 buys
| Insider | Role | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Hussain Abbas | director | Sell | −5,682 | $265.0K | May 01, 2026 |
| Klinger Shannon Thyme | officer: Chief Legal Officer | Sell | −13,885 | $726.0K | Mar 02, 2026 |
| Hoge Stephen | officer: President | Sell | −160,009 | $7.8M | Feb 23, 2026 |
| AFEYAN NOUBAR | director | Sell | −23,853 | $703.3K | Dec 11, 2025 |
| Hussain Abbas | director | Sell | −504 | $13.9K | Dec 09, 2025 |
| Hussain Abbas | director | Sell | −312 | $8.7K | Jun 11, 2025 |
| SAGAN PAUL | director | Buy | +31,620 | $1.0M | Mar 03, 2025 |
| Bancel Stephane | director, officer: Chief Executive Officer | Buy | +57,493 | $1.8M | Mar 03, 2025 |
| Bancel Stephane | director, officer: Chief Executive Officer | Buy | +102,821 | $3.2M | Mar 03, 2025 |
| Klinger Shannon Thyme | officer: Chief Legal Officer | Sell | −529 | $23.6K | Dec 09, 2024 |
| Hoge Stephen | officer: President | Sell | −314 | $13.6K | Dec 03, 2024 |
| Klinger Shannon Thyme | officer: Chief Legal Officer | Sell | −112 | $4.8K | Dec 03, 2024 |
| Klinger Shannon Thyme | officer: Chief Legal Officer | Sell | −1,418 | $60.7K | Nov 29, 2024 |
| Hoge Stephen | officer: President | Sell | −291 | $12.5K | Nov 29, 2024 |
Transaction mix · 730d
62%
Sells20 · $9.9M
Buys3 · $6.0M
Top sellers · 730d
Hoge Stephen · officer: President−$7.9M
Klinger Shannon Thyme · officer: Chief Legal Officer−$877.2K
AFEYAN NOUBAR · director−$703.3K
Transactions
23
3 buys · 20 sells
Bought
$6.01M
Open market
Sold
$9.89M
Open market
Net flow
−$3.88M
Buys − sells
Transactions
| Insider | Role | Action | Shares | Price | Value | Trade date | Filing |
|---|---|---|---|---|---|---|---|
| Hussain Abbas | director | Sell | 5,682 | $46.63 | $264.95K | May 01, 2026 | May 04, 2026 |
| Klinger Shannon Thyme | officer: Chief Legal Officer | Sell | 13,885 | $52.29 | $726.05K | Mar 02, 2026 | Mar 03, 2026 |
| Hoge Stephen | officer: President | Sell | 160,009 | $48.84 | $7.81M | Feb 23, 2026 | Feb 25, 2026 |
| AFEYAN NOUBAR | director | Sell | 23,853 | $29.49 | $703.31K | Dec 11, 2025 | Dec 15, 2025 |
| Hussain Abbas | director | Sell | 504 | $27.60 | $13.91K | Dec 09, 2025 | Dec 11, 2025 |
| Hussain Abbas | director | Sell | 312 | $28.00 | $8.74K | Jun 11, 2025 | Jun 12, 2025 |
| SAGAN PAUL | director | Buy | 31,620 | $31.76 | $1M | Mar 03, 2025 | Mar 04, 2025 |
| Bancel Stephane | director, officer: Chief Executive Officer | Buy | 57,493 | $31.53 | $1.81M | Mar 03, 2025 | Mar 04, 2025 |
| Bancel Stephane | director, officer: Chief Executive Officer | Buy | 102,821 | $31.04 | $3.19M | Mar 03, 2025 | Mar 04, 2025 |
| Klinger Shannon Thyme | officer: Chief Legal Officer | Sell | 529 | $44.68 | $23.64K | Dec 09, 2024 | Dec 10, 2024 |
| Hoge Stephen | officer: President | Sell | 314 | $43.30 | $13.6K | Dec 03, 2024 | Dec 04, 2024 |
| Klinger Shannon Thyme | officer: Chief Legal Officer | Sell | 112 | $43.30 | $4.85K | Dec 03, 2024 | Dec 04, 2024 |
| Klinger Shannon Thyme | officer: Chief Legal Officer | Sell | 1,418 | $42.79 | $60.67K | Nov 29, 2024 | Dec 02, 2024 |
| Hoge Stephen | officer: President | Sell | 291 | $42.79 | $12.45K | Nov 29, 2024 | Dec 02, 2024 |
| Mock James M | officer: Chief Financial Officer | Sell | 1,420 | $42.79 | $60.76K | Nov 29, 2024 | Dec 02, 2024 |
| Hoge Stephen | officer: President | Sell | 277 | $46.10 | $12.77K | Nov 11, 2024 | Nov 12, 2024 |
| Mock James M | officer: Chief Financial Officer | Sell | 715 | $60.12 | $42.99K | Oct 07, 2024 | Oct 08, 2024 |
| Klinger Shannon Thyme | officer: Chief Legal Officer | Sell | 551 | $73.57 | $40.54K | Sep 09, 2024 | Sep 10, 2024 |
| Hoge Stephen | officer: President | Sell | 318 | $76.99 | $24.48K | Sep 03, 2024 | Sep 04, 2024 |
| Klinger Shannon Thyme | officer: Chief Legal Officer | Sell | 114 | $76.99 | $8.78K | Sep 03, 2024 | Sep 04, 2024 |
| Mock James M | officer: Chief Financial Officer | Sell | 162 | $78.03 | $12.64K | Aug 29, 2024 | Aug 30, 2024 |
| Hoge Stephen | officer: President | Sell | 300 | $78.03 | $23.41K | Aug 29, 2024 | Aug 30, 2024 |
| Klinger Shannon Thyme | officer: Chief Legal Officer | Sell | 162 | $78.03 | $12.64K | Aug 29, 2024 | Aug 30, 2024 |
By insider
- Hoge Stephen−$7.9Mofficer: President0B · 6S
- Bancel Stephane+$5Mdirector, officer: Chief Executive Officer2B · 0S
- SAGAN PAUL+$1Mdirector1B · 0S
- Klinger Shannon Thyme−$877.16Kofficer: Chief Legal Officer0B · 7S
- AFEYAN NOUBAR−$703.31Kdirector0B · 1S
- Hussain Abbas−$287.6Kdirector0B · 3S
- Mock James M−$116.39Kofficer: Chief Financial Officer0B · 3S
Beneficial ownership filings
Schedule 13D / 13G — investors holding more than 5% of MRNA-US.
DB · acquisition_ownership11
| Filed | Reporting person | Form | Type | Aggregate owned | % Class | Sole voting | Shared voting | Citizenship | |
|---|---|---|---|---|---|---|---|---|---|
| Feb 14, 2022 | IV-Rx, | — | PN | — | +0.70% | 0 | 2.84M | — | SEC → |
| Feb 14, 2022 | Fund IV General Partner LLC | — | OO | — | +4.30% | 0 | 17.58M | — | SEC → |
| Feb 14, 2022 | Ph.D. | — | IN | — | +4.90% | 2.39M | 17.61M | — | SEC → |
| Feb 14, 2022 | 7.64% (2) | — | IN | — | +7.64% | 31.54M | 0 | France | SEC → |
| Feb 14, 2022 | Pioneering, Inc. | — | CO | — | +0.10% | 37.04K | 0 | — | SEC → |
| Feb 14, 2022 | VentureLabs IV, LLC | — | OO | — | +2.80% | 0 | 11.46M | — | SEC → |
| Feb 14, 2022 | Fund IV, LP | — | PN | — | +3.60% | 0 | 14.74M | — | SEC → |
| Feb 10, 2022 | The Vanguard Group - 23-1945930 | — | IA | — | +6.76% | 0 | 595.8K | Pennsylvania For | SEC → |
| Feb 04, 2022 | (1) BlackRock, Inc. | — | HC | — | +6.80% | 24.97M | 0 | Delaware | SEC → |
| Jan 26, 2022 | Baillie Gifford & Co (Scottish partnership) | — | IA | — | +11.00% | 0 | 0 | SCOTLAND UK | SEC → |
| Jul 12, 2021 | (1) BlackRock, Inc. | — | HC | — | +4.80% | 17.3M | 0 | Delaware | SEC → |
Top 10 holders · 8 quarters
13F position evolutionNo 13F history in
institutional_holders for MRNA-US.